戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sufficiently pure to support high-efficiency nucleic acid amplification.
2 ccurate thermal control and the detection of nucleic acid amplification.
3 pe biosensor compared favorably to those for nucleic acid amplification.
4 body tests were tested again with the use of nucleic acid amplification.
5 ng aptamer labels, hybridization assays, and nucleic acid amplification.
6 chomatis were detected from vaginal swabs by nucleic acid amplification.
7 tion of single-cell genomic DNA using linear nucleic acid amplification.
8 ons were identified only with the use of the nucleic acid amplification algorithm.
9 dimensionality and sensitive detection using nucleic acid amplification and analysis techniques.
10 echnologies for milk analysis, in particular nucleic acid amplification and biosensors, is reviewed h
11          Integrating sample preparation with nucleic acid amplification and detection in a cost-effec
12                                              Nucleic acid amplification and detection plays an increa
13 ne clinical laboratory use by automating the nucleic acid amplification and detection processes.
14 y describe recent developments in isothermal nucleic acid amplification and detection, and focus on e
15 using simple methods of sequence-independent nucleic acid amplification and limited sequencing.
16                 The assay involved multiplex nucleic acid amplification and microarray hybridization
17 x priming amplification, to greatly simplify nucleic acid amplification and real-time quantification
18  other biological assays, such as isothermal nucleic acid amplification and restriction enzyme digest
19 Direct molecular assay (ST Direct) relies on nucleic acid amplification and solid array-based amplico
20 rmined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of
21 munoassays, and orthogonal, multiplexed PCR (nucleic acid) amplification and detection.
22 or microbial nucleic acid enrichment, random nucleic acid amplification, and automated sequence simil
23  been utilised to develop a novel isothermal nucleic acid amplification assay (SMART) for the detecti
24 icroscopy with the GeneXpert MTB/RIF (Xpert) nucleic acid amplification assay could reduce testing ti
25 utomated assay provides a useful alternative nucleic acid amplification assay for clinical laboratori
26 nty that contamination has occurred during a nucleic acid amplification assay in the absence of a pos
27 latform in which a simple, dry-reagent-based nucleic acid amplification assay is combined with a port
28   We have developed a specific and sensitive nucleic acid amplification assay that is suitable for ro
29 e potential of combining a dry-reagent-based nucleic acid amplification assay with an electrochemical
30 ion window duration was demonstrated using a nucleic acid amplification assay, the Procleix HIV-1/HCV
31 verse transcription PCR (RT-PCR), and TaqMan nucleic acid amplification assays for the rapid detectio
32                                              Nucleic acid amplification assays had limited abilities
33              In addition, all three types of nucleic acid amplification assays have been used to dete
34 assay to results from two currently approved nucleic acid amplification assays in 1,722 female and 1,
35                     While all three types of nucleic acid amplification assays provide rapid detectio
36                                   Isothermal nucleic acid amplification assays such as the loop media
37 croBAR is capable of carrying out isothermal nucleic acid amplification assays with real-time fluores
38                                 When used in nucleic acid amplification assays, gene detection is hom
39 o the species level by phenotypic systems or nucleic acid amplification assays.
40 edure has not transformed the application of nucleic acid amplification assays.
41           Clinical diagnostic tests based on nucleic acid amplification assist with the prompt diagno
42 lood products can be achieved by a sensitive nucleic acid amplification-based assay.
43 ey components necessary to expand the use of nucleic acid amplification-based detection assays toward
44 king this region a target of choice for most nucleic acid amplification-based detection assays.
45 mic range for the new Xpert MTB/RIF assay, a nucleic acid amplification-based diagnostic system that
46                                       Use of nucleic acid amplification-based diagnostic tests on fir
47  Molecular typing is an important adjunct to nucleic acid amplification-based diagnostics.
48       Alere i Influenza A&B is an isothermal nucleic acid amplification-based integrated system for d
49 rains from direct clinical samples used with nucleic acid amplification-based tests.
50  assembly (CHA) is one of the most promising nucleic acid amplification circuits based on toehold-med
51 he sensitivity, specificity, and rapidity of nucleic acid amplification demonstrate the usefulness of
52 pped with a sample pretreatment device and a nucleic acid amplification device for the rapid diagnosi
53 ave been made in the development of portable nucleic acid amplification devices for near-patient use.
54 ction of viral RNA in both tests is based on nucleic acid amplification followed by hybridization to
55                                              Nucleic acid amplification includes both polymerase chai
56 erebrospinal fluid (CSF) and the presence of nucleic acid amplification inhibitors.
57                                              Nucleic acid amplification is an essential process in bi
58                                   Isothermal nucleic acid amplification is becoming increasingly impo
59 integrated with real-time DNA/RNA isothermal nucleic acid amplification: Loop-mediated isothermal amp
60 acement amplification (SDA) is an isothermal nucleic acid amplification method based on the primer-di
61 ation (LAMP) of DNA is a powerful isothermal nucleic acid amplification method that can generate upwa
62 est, Staph ID/R, combines a rapid isothermal nucleic acid amplification method, helicase-dependent am
63 (CDC) recommends the performance of a direct nucleic acid amplification method, regardless of smear r
64      We recently reported a novel isothermal nucleic acid amplification method, Strand Invasion-Based
65                      Often, a more sensitive nucleic acid amplification method, such as PCR, is requi
66   Using the DNase-sequence-independent viral nucleic acid amplification method, we identified several
67                                    Real-time nucleic acid amplification methods can be extremely usef
68                        Our results show that nucleic acid amplification methods can serve to detect C
69 aboratory diagnosis, rapid antigen tests and nucleic acid amplification methods may also play a usefu
70                                   Isothermal nucleic acid amplification methods offer significant adv
71                                              Nucleic acid amplification methods such as the PCR have
72                                      Current nucleic acid amplification methods to detect Mycobacteri
73  and other NGU pathogens were detected using nucleic acid amplification methods, and DNA sequencing w
74                                          For nucleic acid amplification methods, controlled DNA denat
75 hese limitations, with a focus on isothermal nucleic acid amplification methods.
76 g of both isothermal and temperature-cycling nucleic acid amplification methods.
77 xponential target amplifications provided by nucleic acid amplification methods.
78  and Prevention's Mycobacterium tuberculosis nucleic acid amplification (NAA) evaluation program, 27.
79 nder conditions appropriate for evaluating a nucleic acid amplification (NAA) test for Chlamydia trac
80 llent performance of rapid tuberculosis (TB) nucleic acid amplification (NAA) tests and the clear ben
81 t system (BD Affirm VPIII) was compared with nucleic acid amplification (NAA)-based assays for determ
82                                              Nucleic acid amplification of biomarkers is increasingly
83 equencing DNA microarrays with either random nucleic acid amplification or multiplex PCR for GAS dete
84                          Currently available nucleic acid amplification platforms for tuberculosis (T
85 c devices of the most popular technology for nucleic acids amplifications, polymerase chain reaction
86 ntial, numerous technical issues, especially nucleic acid amplification, probe specificity, and inter
87 n developed from an understanding of natural nucleic acid amplification processes.
88 ircuitry can be used to transduce isothermal nucleic acid amplification products into signals that ca
89 g and transducing signals at the terminus of nucleic acid amplification reactions.
90 on-specific amplification in EXPAR and other nucleic acid amplification reactions.
91  integration of blood sample preparation and nucleic acid amplification reactions.
92 idic systems for the compartmentalization of nucleic acid amplification reactions.
93  field effect transistor methods for sensing nucleic acid amplification rely on establishing the flui
94 nical laboratory include biological culture, nucleic acid amplification, ribosomal protein characteri
95 ing was observed, the failure was due to the nucleic acid amplification step rather than limitations
96                                              Nucleic acid amplification strategies and advances in am
97 C. difficile assay is an integrated, closed, nucleic acid amplification system that automates sample
98 ert Flu Assay cartridge is a next-generation nucleic acid amplification system that provides multiple
99 ation of DNA (LAMP) is a powerful isothermal nucleic acid amplification technique that can accumulate
100 esults in the negative gray zone by use of a nucleic acid amplification technique, is not suitable fo
101  (MTD) is a rapid diagnostic test based on a nucleic acid amplification technique, which can be used
102 omewhat limited applications of this classic nucleic acid amplification technique.
103                                   Performing nucleic acid amplification techniques (NAATs) in digital
104                                              Nucleic acid amplification techniques (polymerase chain
105 ion of these methods that are independent of nucleic acid amplification techniques and could largely
106                                              Nucleic acid amplification techniques for the diagnosis
107                           Recent advances in nucleic acid amplification techniques have allowed for q
108                                              Nucleic acid amplification techniques have been among th
109                                      Several nucleic acid amplification techniques have been develope
110                       Recent developments in nucleic acid amplification techniques now allow the rapi
111                                              Nucleic acid amplification techniques such as the PCR ar
112  broad range of assays, including isothermal nucleic acid amplification techniques, enzyme-based immu
113 cluding both antigen detection and multiplex nucleic acid amplification techniques, is becoming more
114 re hospitals were tested for influenza using nucleic acid amplification techniques.
115                             Rapid isothermal nucleic acid amplification technologies can enable diagn
116                          The availability of nucleic acid amplification technologies may make noninva
117 o known as hyperbranched RCA) are isothermal nucleic acid amplification technologies that have gained
118 first international standard for HBV DNA for nucleic acid amplification technology (NAT) assays.
119 study period, which was analyzed relative to nucleic acid amplification technology (NAT) yield to est
120 ncy virus type 1 (HIV-1) RNA copy numbers by nucleic acid amplification technology (the NASBA HIV-1 R
121 in the input volume of specimens analyzed by nucleic acid amplification technology can be useful for
122 e compared to those from culture and the LCx nucleic acid amplification test (Abbott Industries, Abbo
123 ratory viral panel (eSensor RVP) multiplexed nucleic acid amplification test (GenMark Diagnostics, In
124 FilmArray Respiratory Panel (RP) multiplexed nucleic acid amplification test (Idaho Technology, Inc.,
125     This work presents an on-chip isothermal nucleic acid amplification test (iNAAT) for the multiple
126 sitive for stx by an alternative FDA-cleared nucleic acid amplification test (NAAT) but were negative
127 2) is a Food and Drug Administration-cleared nucleic acid amplification test (NAAT) for the detection
128           The Abbott RealTime MTB assay is a nucleic acid amplification test (NAAT) for the detection
129          To investigate the performance of a nucleic acid amplification test (NAAT) for the diagnosis
130 atis or N. gonorrhoeae, two or more positive nucleic acid amplification test (NAAT) results, or a sin
131 seria gonorrhoeae (gonococcus [GC])-positive nucleic acid amplification test (NAAT) results: (i) repe
132                                Culture and a nucleic acid amplification test (NAAT) were used to dete
133 s and symptoms, in contrast with only 3 of 8 nucleic acid amplification test (NAAT)-based studies (P
134 sistant tuberculosis (MDR-TB) screening, all nucleic acid amplification test (NAAT)-positive respirat
135  even more specific if it were compared to a nucleic acid amplification test (NAAT).
136 ave developed an economical, high-throughput nucleic acid amplification test (NAT) for blood-borne vi
137 sts (wet mount, culture, a rapid test, and a nucleic acid amplification test [NAAT]) were performed o
138 ,749 vulvovaginal-swab specimens with both a nucleic acid amplification test and a polymer conjugate-
139  true-negative or false-negative relative to nucleic acid amplification test and/or enzyme immunoassa
140    The Alere i strep A test is an isothermal nucleic acid amplification test designed to offer highly
141  at first vaginal intercourse and a positive nucleic acid amplification test for sexually transmitted
142 ple, sample-to-answer, on-demand, multiplex, nucleic acid amplification test for syndromic diagnosis
143  Qiagen artus C. difficile QS-RGQ kit, a new nucleic acid amplification test for the detection of Clo
144 opment of an internally controlled multiplex nucleic acid amplification test for the detection of den
145                    Rapid implementation of a nucleic acid amplification test led to the prospective i
146  defined as a confirmed positive result on a nucleic acid amplification test or as HIV antibody seroc
147                        In addition, positive nucleic acid amplification test results should be confir
148   The Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification test widely used in settings
149 t results were resolved using an alternative nucleic acid amplification test.
150 ify reactive specimens for confirmation by a nucleic acid amplification test.
151 t MTB/RIF (Xpert), a novel, semiautomated TB nucleic-acid amplification test, has renewed interest in
152 of 3 algorithms that detect AHI based on HIV nucleic acid amplification testing (EarlyTest algorithm)
153   Here we report the development of a mobile nucleic acid amplification testing (mobiNAAT) platform u
154 utility of Mycobacterium tuberculosis direct nucleic acid amplification testing (MTD) for pulmonary t
155 rator for improving the harmonization of BKV nucleic acid amplification testing (NAAT) and enabling c
156 tion of Chlamydia trachomatis were tested by nucleic acid amplification testing (NAAT) and in cell cu
157  We evaluated criteria to reduce unnecessary nucleic acid amplification testing (NAAT) for viral path
158                                              Nucleic acid amplification testing (NAAT) has become the
159                                              Nucleic acid amplification testing (NAAT) is increasingl
160                                              Nucleic acid amplification testing (NAAT) is the preferr
161  virus infection (AHI); however, the cost of nucleic acid amplification testing (NAAT) makes individu
162 onreactive samples were pooled and tested by nucleic acid amplification testing (NAAT) to identify ac
163                         Cervical culture and nucleic acid amplification testing (NAAT) were completed
164                                     However, nucleic acid amplification testing (NAAT) with the Xpert
165 chomatis infection in certain populations by nucleic acid amplification testing (NAAT), as they invol
166      This study presents the verification of nucleic acid amplification testing (NAAT; Gen-Probe Apti
167 ccepted for transplantation.Universal use of nucleic acid amplification testing (NAT) for the screeni
168 igenic organisms (toxigenic culture [TC] and nucleic acid amplification testing [NAAT]) are confounde
169    The primary outcome was microbial cure by nucleic acid amplification testing at day 28.
170 imens, a useful characteristic in the age of nucleic acid amplification testing for gonococcal infect
171    For all urine specimens, UA, culture, and nucleic acid amplification testing for Neisseria gonorrh
172                     North Carolina has added nucleic acid amplification testing for the human immunod
173 f C. trachomatis- or N. gonorrhoeae-specific nucleic acid amplification testing in this metropolitan
174 the introduction of diagnostic M. genitalium nucleic acid amplification testing including antimicrobi
175                                              Nucleic acid amplification testing is a very powerful me
176       These data support the use of targeted nucleic acid amplification testing of individual donatio
177                                     Although nucleic acid amplification testing of minipools of blood
178                   To determine the effect of nucleic acid amplification testing on the yield and accu
179      Screening of broth enrichment fluids by nucleic acid amplification testing requires careful hand
180                              The addition of nucleic acid amplification testing to an HIV testing alg
181 tly, some laboratories have begun adding HIV nucleic acid amplification testing to HIV diagnostic tes
182 est yield on minipool testing, retrospective nucleic acid amplification testing was performed on indi
183 dictive value of the algorithm that included nucleic acid amplification testing were greater than 0.9
184                                     Although nucleic acid amplification testing would detect N. gonor
185 specimens, known to be gonorrhea positive by nucleic acid amplification testing, provided by females
186 treatment failure determined on the basis of nucleic acid amplification testing, sexual history, and
187 erpretation of gonorrhea tests of cure using nucleic acid amplification testing, this study examined
188  acutely viremic blood donors, identified by nucleic acid amplification testing, were enrolled and mo
189  in whom WNV infection was identified by WNV nucleic acid amplification testing.
190 ts and laboratory-based specimen pooling for nucleic acid amplification testing.
191 other month were tested for M. genitalium by nucleic acid amplification testing.
192 ymptomatic sexual health screening underwent nucleic acid amplification testing; positive samples and
193                                     Minipool nucleic acid-amplification testing has helped prevent th
194 rmed to be positive for HIV-1 and HCV RNA on nucleic acid-amplification testing of "minipools" (pools
195                              The addition of nucleic acid-amplification testing to the screening of t
196                  We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium
197  testing practices since the introduction of nucleic acid amplification tests (NAAT), we surveyed lab
198 uction of rapid serologic tests (RT) and HIV nucleic acid amplification tests (NAAT).
199                                   Commercial nucleic acid amplification tests (NAATs) are becoming av
200 lty of culture of this fastidious bacterium, nucleic acid amplification tests (NAATs) are necessary f
201                                              Nucleic acid amplification tests (NAATs) are quickly bec
202                                              Nucleic acid amplification tests (NAATs) are reliable to
203 ning from toxin enzyme immunoassays (EIA) to nucleic acid amplification tests (NAATs) as the primary
204                                              Nucleic acid amplification tests (NAATs) can be used to
205                                      Because nucleic acid amplification tests (NAATs) do not distingu
206 suggested approaches for confirming positive nucleic acid amplification tests (NAATs) for Chlamydia t
207                   The greater sensitivity of nucleic acid amplification tests (NAATs) for Chlamydia t
208 is study was to determine the added value of nucleic acid amplification tests (NAATs) for detection o
209 cent sexual assault survivors include use of nucleic acid amplification tests (NAATs) for detection o
210                                              Nucleic acid amplification tests (NAATs) for enterovirus
211  rapid development of commercially available nucleic acid amplification tests (NAATs) for influenza v
212 r, the true limitation in the realization of nucleic acid amplification tests (NAATs) for near-patien
213 udy evaluated the performance of culture and nucleic acid amplification tests (NAATs) for rectal chla
214                                              Nucleic acid amplification tests (NAATs) for the detecti
215         Currently, there are no FDA-approved nucleic acid amplification tests (NAATs) for the detecti
216 was to define the performance of culture and nucleic acid amplification tests (NAATs) for the diagnos
217                      The currently available nucleic acid amplification tests (NAATs) for trichomonia
218 self-obtained vaginal specimens processed by nucleic acid amplification tests (NAATs) has significant
219                                    Recently, nucleic acid amplification tests (NAATs) have been appro
220 ple, recent studies with ribosomal RNA-based nucleic acid amplification tests (NAATs) have demonstrat
221                                              Nucleic acid amplification tests (NAATs) have frequently
222                                              Nucleic acid amplification tests (NAATs) have revolution
223 DTs), digital immunoassays (DIAs), and rapid nucleic acid amplification tests (NAATs) in children and
224 a CT (ACT) (Hologic Inc., San Diego, CA) are nucleic acid amplification tests (NAATs) that detect Chl
225 . Food and Drug Administration (FDA)-cleared nucleic acid amplification tests (NAATs) to culture usin
226                                   The use of nucleic acid amplification tests (NAATs) to diagnose Nei
227                           The specificity of nucleic acid amplification tests (NAATs) used for early
228 ribing the diagnostic performance of malaria nucleic acid amplification tests (NAATs) using these spe
229 , and illumigene group B Streptococcus (GBS) nucleic acid amplification tests (NAATs) were compared t
230                                At that time, nucleic acid amplification tests (NAATs) were just becom
231 ests for Chlamydia trachomatis have compared nucleic acid amplification tests (NAATs) with diagnostic
232       The use of nonculture methods, such as nucleic acid amplification tests (NAATs), to evaluate pr
233 tinct MAMEF assays were compared to those of nucleic acid amplification tests (NAATs).
234 rus (DENV) detection, including a variety of nucleic acid amplification tests (NAATs).
235 sed to confirm the results of more sensitive nucleic acid amplification tests (NAATs).
236 lticenter study evaluated that specimen with nucleic acid amplification tests (NAATs).
237 ulture-based systems, simplified versions of nucleic acid amplification tests (such as the Xpert MTB/
238 ine whether test performance measures of two nucleic acid amplification tests and a DNA probe were af
239 tive donations were confirmed by alternative nucleic acid amplification tests and IgM and IgG tests,
240 es and gaining in use are techniques such as nucleic acid amplification tests and mass spectroscopy t
241                                              Nucleic acid amplification tests and point-of-care tests
242 genitalium coinfections were evaluated using nucleic acid amplification tests and were negative at 1
243                                              Nucleic acid amplification tests are accurate for diagno
244 proaches to diagnosis remain inaccurate, and nucleic acid amplification tests are also compromised by
245                                              Nucleic acid amplification tests are increasingly used t
246 ting areas of the clinical spectrum in which nucleic acid amplification tests can make an important c
247  In 10 new studies of asymptomatic patients, nucleic acid amplification tests demonstrated sensitivit
248                                              Nucleic acid amplification tests detected CT, MG, and TV
249  gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification tests detects greater numbers
250 ly impact the performance characteristics of nucleic acid amplification tests for B. pertussis.
251                                   Results of nucleic acid amplification tests for C. trachomatis on u
252          We evaluated the performance of two nucleic acid amplification tests for detecting Chlamydia
253         We compared two rapid, point-of care nucleic acid amplification tests for detection of influe
254                             Since diagnostic nucleic acid amplification tests for gonococci are now i
255  between liquid cytologic media and multiple nucleic acid amplification tests for the detection of C.
256                        In laboratory trials, nucleic acid amplification tests for the diagnosis of tu
257 ree commercial identification kits and three nucleic acid amplification tests for the identification
258                                              Nucleic acid amplification tests for Trichomonas vaginal
259                                              Nucleic acid amplification tests have become a common me
260                                        While nucleic acid amplification tests have great potential as
261                                              Nucleic acid amplification tests identify BI/NAP1/027 ra
262 dia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification tests is an attractive altern
263                                   The use of nucleic acid amplification tests of "minipools" of 16 sa
264 ions and the incremental yield and safety of nucleic acid amplification tests of individual donations
265                                              Nucleic acid amplification tests offer superior sensitiv
266 retrospectively using enzyme immunoassay and nucleic acid amplification tests on stored specimens.
267 nd discrepancies were resolved by additional nucleic acid amplification tests or sequencing.
268               The increased sensitivities of nucleic acid amplification tests such as ligase chain re
269  In many clinical microbiology laboratories, nucleic acid amplification tests such as PCR have become
270                                              Nucleic acid amplification tests such as PCR have signif
271                                              Nucleic acid amplification tests such as the BDProbeTec
272 y have residual DNA in sputum that confounds nucleic acid amplification tests such as Xpert MTB/RIF.
273 rovide valid specimens for HPV testing using nucleic acid amplification tests, although a few cytolog
274 imens from women are suitable substrates for nucleic acid amplification tests, but enzyme immunoassay
275 strategies, newer testing methods, including nucleic acid amplification tests, have enhanced sensitiv
276  Emerging POC microbiology tests, especially nucleic acid amplification tests, have the potential to
277 n will expand the diagnostic applications of nucleic acid amplification tests, in particular for near
278 that evaluated 1 of 3 commercially available nucleic acid amplification tests, included data from tes
279                               Development of nucleic acid amplification tests, such as the ligase cha
280   With a reference standard of two different nucleic acid amplification tests, the sensitivity and sp
281 (UU-2), and Trichomonas vaginalis (TV) using nucleic acid amplification tests.
282     There were two false positive results on nucleic acid amplification tests.
283 reatly expand the diagnostic applications of nucleic acid amplification tests.
284 le virus RNA with the use of investigational nucleic acid amplification tests; testing was performed
285 lection agencies implemented West Nile virus nucleic acid-amplification tests to identify infected do
286 e respective rates of positive HCV and HIV-1 nucleic acid-amplification tests were 3.3 and 4.1 times
287 horolysis-activated polymerization [PAP]) of nucleic acid amplification that uses 3' blocked primers
288 e quantitative electrochemical monitoring of nucleic acid amplification through PCR is a promising re
289                      Electrical detection of nucleic acid amplification through pH changes associated
290 urists and restaurant staff were examined by nucleic acid amplification using reverse transcription p
291 -activated polymerization (PAP), a method of nucleic acid amplification using serial coupling of pyro
292  and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United
293                                    Real-time nucleic acid amplification, whereby the amplification ra

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top